Literature DB >> 5416835

Therapeutic effects of hydroxyurea. Experience with 118 patients with inoperable solid tumors.

I M Ariel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5416835     DOI： 10.1002/1097-0142(197003)25:3<705::aid-cncr2820250331>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  10 in total

Review 1.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

Review 2.  Pharmacokinetics and pharmacodynamics of hydroxyurea.

Authors:  P R Gwilt; W G Tracewell
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

3.  [Studies on synchronisation in vivo: temporary inhibition of DNA synthesis in normal and malignant mammalian cell systems with hydroxyurea].

Authors:  M F Rajewsky; D F Hülser; E Fabricius
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1971

4.  Phase 1 study of high-dose hydroxyurea in lung cancer.

Authors:  D Veale; B M Cantwell; N Kerr; A Upfold; A L Harris
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

5.  Chromosome damage and repair in children with sickle cell anaemia and long-term hydroxycarbamide exposure.

Authors:  Patrick T McGann; Thad A Howard; Jonathan M Flanagan; Jill M Lahti; Russell E Ware
Journal:  Br J Haematol       Date:  2011-05-04       Impact factor: 6.998

Review 6.  Cancer chemotherapy: past, present, and future--Part I.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1984-08       Impact factor: 1.798

Review 7.  Hydroxyurea therapy for sickle cell anemia.

Authors:  Patrick T McGann; Russell E Ware
Journal:  Expert Opin Drug Saf       Date:  2015-09-14       Impact factor: 4.250

8.  A phase I trial of high-dose continuous-infusion hydroxyurea.

Authors:  D C Smith; W P Vaughan; P R Gwilt; D L Trump
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

9.  A cytotoxic DNA precursor is taken up selectively by human cancer xenografts.

Authors:  K D Bagshawe; J Boden; G M Boxer; D W Britton; A Green; T Partridge; B Pedley; S Sharma; P Southall
Journal:  Br J Cancer       Date:  1987-03       Impact factor: 7.640

10.  The influence of high dose hydroxyurea on the incorporation of 5-iodo-2-deoxyuridine (IUdR) by human bone marrow and tumour cells in vivo.

Authors:  P A Philip; L Kaklamanis; J Carmichael; K Tonkin; H Morrison; K Gatter; A L Harris
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.